ABL1 and myeloid leukemia: On the other hand, the results showed that the combination of imatinib and quercetin as a nano-drug complex has a synergistic effect on the induction of apoptosis in imatinib-resistant BCR-ABL positive chronic human myeloid leukemia cells.